News
White Falcon Capital's Q1 2025 letter discusses their take on tariffs, provides a portfolio update, and presents an ...
For the first quarter of 2025, a Class A investment in Laughing Water Capital returned approximately -13%. Over the same ...
Decibel Cannabis is poised for a revaluation as it returns to growth in 2025, according to a new report from Ventum Capital ...
Letter outlines Phase 3 timeline for PrimeC in ALS, provides update on Canadian regulatory pathway and strategic partnership discussions; Company optimistic about ongoing ...
Despite a forward P/E of 83.1x, Tesla’s high valuation, mixed analyst sentiment, and insider selling suggest holding current ...
Besides generics, Dr. Reddy’s has committed a lot of resources to develop its biosimilars as well as new chemical entity business. Biosimilars have been seen as a growth engine for large, capable ...
While many investors have been scared away from tech giants at the center of this year’s equity rout, the companies are ...
These have trapped capital worth over $30 billion on their balance sheets, with market caps ranging from $5 million ... our global network of life sciences reporters. Receive The Pharma Letter daily ...
TUCSON, Ariz., April 18, 2025 /PRNewswire/ -- Blessing Capital, an emerging firm in the alternative commercial finance space, has officially announced the launch of its Letter of Credit Program.
6h
TipRanks on MSNAlphabet backs FY25 capital expenditures view $75BSays YouTube has over 1B monthly active podcast users. Says Waymo serving 250,000 passengers each week. Says Waymo continues progressing on ...
David Einhorn's hedge fund Greenlight Capital posted an 8.2% return in the first quarter. In a letter to investors, Greenlight said gold was "by far the biggest winner" in its portfolio.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results